During the past decade, CH La Rochelle conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 10 clinical trials were completed, i.e. on average, 13.9% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 9 clinical trials were completed. i.e. 26.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH La Rochelle" #1 sponsor was "Groupe Hospitalier de la Rochelle Ré Aunis" with 12 trials, followed by "Nantes University Hospital" with 9 trials sponsored, "Poitiers University Hospital" with 6 trials sponsored, "Centre Hospitalier Departemental Vendee" with 4 trials sponsored and "Medtronic" with 4 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH La Rochelle" #1 collaborator was "Medtronic" with 3 trials as a collaborator, "Floralis" with 2 trials as a collaborator, "Groupe Hospitalier de la Rochelle Ré Aunis" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator and "Ministry of Health, France" with 2 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "CH La Rochelle" are "Heart Failure" (5 trials), "Atrial Fibrillation" (3 trials), "Coronary Artery Disease" (3 trials), "Alternative Method of Apnea Test" (2 trials) and "Critical Illness" (2 trials). Many other conditions were trialed in "CH La Rochelle" in a lesser frequency.

Most popular intervention types in "CH La Rochelle" are "Device" (21 trials), "Drug" (20 trials), "Other" (17 trials), "Procedure" (12 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apnea test - CPAP" (2 trials), "Bleomycin" (2 trials), "Doxorubicin" (2 trials) and "25mmHg ECS" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH La Rochelle" are 85 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CH La Rochelle". 2 are not yet recruiting, 24 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in CH La Rochelle, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CH La Rochelle, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 25 trials that are defined as “Not Applicable".